Literature DB >> 8085138

Is the modality-shift effect specific for schizophrenia patients?

R Ferstl1, R Hanewinkel, P Krag.   

Abstract

Several studies have found that the reaction time of schizophrenia patients is longer when successive imperative stimuli are of different modality (e.g., light followed by sound) than when they are identical (e.g., sound followed by sound). This effect is called the modality-shift effect. In this study, the reaction times of 175 persons were analyzed: 54 schizophrenia patients, 33 patients with mood disorders, 13 alcoholics, 17 patients with rheumatoid arthritis, 13 patients with internal diseases, and 45 normal controls. The results indicated that a shift from light to sound stimuli lengthened the reaction time for schizophrenia patients considerably more than for alcoholics, patients with rheumatoid arthritis, patients with internal diseases, or normal controls. No difference was found between the reaction times of schizophrenia patients and patients with mood disorders.

Entities:  

Mesh:

Year:  1994        PMID: 8085138     DOI: 10.1093/schbul/20.2.367

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  4 in total

1.  Modality shift effects mimic multisensory interactions: an event-related potential study.

Authors:  Matthias Gondan; Dirk Vorberg; Mark W Greenlee
Journal:  Exp Brain Res       Date:  2007-06-12       Impact factor: 1.972

2.  Delusional Ideation, Cognitive Processes and Crime Based Reasoning.

Authors:  Dean J Wilkinson; Laura S Caulfield
Journal:  Eur J Psychol       Date:  2017-08-31

3.  Processing time not modality dominates shift costs in the modality-shifting effect.

Authors:  Hettie Roebuck; Kun Guo; Patrick Bourke
Journal:  Psychol Res       Date:  2019-12-14

4.  Shifting attention between modalities: Revisiting the modality-shift effect in autism.

Authors:  Daniel Poole; Eleanor Miles; Emma Gowen; Ellen Poliakoff
Journal:  Atten Percept Psychophys       Date:  2021-04-30       Impact factor: 2.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.